Avanafil
| 매개변수 | 사양 |
|---|---|
| 제품명 | Avanafil |
| CAS 번호 | 330784-47-9 |
| 분자식 | C23H26ClN7O3 |
| 분자량 | 483.95 g/mol |
| 외관 | 흰색에서 미백색의 결정성 분말 |
| 분석법 (HPLC) | ≥99.0% |
| 용해도 | Soluble in DMSO, slightly soluble in ethanol, practically insoluble in water |
| 패키지 | 25 kg net weight in fiber drums with double polyethylene liners |
도움이 필요하신가요? 저희 팀에 문의해 주세요

동의어: TA-1790, 4-[(3-Chloro-4-methoxybenzyl)amino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide, Avanafilum, Stendra, Spedra, TA 1790
Avanafil is a highly selective phosphodiesterase type 5 (PDE5) inhibitor developed for the treatment of erectile dysfunction. It is a synthetic small-molecule API manufactured under cGMP conditions, available as a white to off-white crystalline powder with an assay of ≥99.0% by HPLC.
Known commercially as Stendra and Spedra, Avanafil is distinguished by its rapid onset of action and high selectivity for PDE5 over other phosphodiesterase isoenzymes, which translates into a favorable side-effect profile. As a bulk API, it serves formulators developing oral solid dosage forms, including immediate-release tablets and orally disintegrating formulations.
| Test Item | 사양 |
|---|---|
| 식별 | IR and HPLC retention time conform to reference standard |
| 건조 손실 | ≤0.5% |
| 소각 잔류물 | ≤0.1% |
| 중금속 | ≤20 ppm |
| Organic Impurities | Any individual impurity ≤0.5%; total impurities ≤1.0% |
| Microbial Limits | Total aerobic count ≤1000 CFU/g; yeast and mold ≤100 CFU/g; absence of E. coli and Salmonella |
Our standard MOQ is 1 kg for stock items. For custom packaging or larger quantities, the MOQ is 25 kg. We can accommodate smaller quantities for research and development upon request.
For stock items, the lead time is 3-5 business days from order confirmation. We ship globally via express couriers and air freight.
Yes, a COA is provided with every shipment. Samples for analytical evaluation are available upon request; sample dispatch typically takes 1-2 days after approval.
send us your specification for a quotation.